CONMED Corporation
CNMD
$33.92
-$0.85-2.45%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 54.85M | 47.06M | 64.07M | 110.20M | 118.75M |
| Total Depreciation and Amortization | 73.67M | 73.08M | 72.04M | 71.40M | 70.67M |
| Total Amortization of Deferred Charges | 6.68M | 6.85M | 6.95M | 7.12M | 7.14M |
| Total Other Non-Cash Items | 43.84M | 55.16M | 43.95M | 15.93M | 10.32M |
| Change in Net Operating Assets | -36.40M | -11.45M | -19.31M | -39.44M | -27.50M |
| Cash from Operations | 142.63M | 170.69M | 167.69M | 165.21M | 179.38M |
| Capital Expenditure | -18.92M | -19.81M | -18.74M | -16.97M | -14.83M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 7.00M | -- | -- | -- | -- |
| Other Investing Activities | -2.00M | -1.15M | 850.00K | 850.00K | 850.00K |
| Cash from Investing | -13.92M | -20.96M | -17.89M | -16.12M | -13.98M |
| Total Debt Issued | 734.67M | 720.67M | 683.67M | 659.67M | 663.00M |
| Total Debt Repaid | -769.67M | -795.25M | -774.25M | -747.25M | -765.59M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -37.02M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -18.57M | -24.75M | -24.73M | -24.71M | -24.68M |
| Other Financing Activities | -39.39M | -36.49M | -34.20M | -32.53M | -35.12M |
| Cash from Financing | -129.98M | -135.82M | -149.52M | -144.83M | -162.38M |
| Foreign Exchange rate Adjustments | 812.00K | 2.45M | 175.00K | 800.00K | -1.39M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -455.00K | 16.36M | 462.00K | 5.07M | 1.63M |